Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-21

Clinical Trial Update: Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring the relationship between improvements in insulin secretion and reductions in HbA1c in GLP-1 receptor agonist therapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dasman Diabetes Institute | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN